Health Technology Assessments (HTA)

The Norwegian Institute of Public Health contributes to national and international Health Technology Assessments.

Reports

Health technology assessment

Published 28.03.2019

Patent foramen ovale closure, antiplatelet therapy or anticoagulation therapy alone for management of cryptogenic stroke

This report evaluates catheter-based PFO closure as an alternative treatment to antiplatelet therapy or anticoagulation for patients with a PFO having suffered a stroke.

Health technology assessment

Published 13.02.2019

Hyperbaric oxygen therapy for osteonecrosis

We have summarized research on the clinical effect and safety HBOT as a treatment for osteonecrosis. We have also examined the cost-effectiveness and budget consequences of HBOT.

Health technology assessment

Published 12.12.2018

Therapist-supported internet therapy for mental disorders

The Norwegian Institute of Public Health was commissioned to prepare a health technology assessment on the use of guided internet treatment for mental disorders (eMeistring).

Health technology assessment

Published 01.10.2018

EXOGEN™ in the treatment of non-union fractures

The present report provides a single technology assessment of EXOGEN™ for the treatment of non-union fractures.

Health technology assessment

Published 26.09.2018

Effectiveness and safety of nitrous oxide as sedation regimen in children – an HTA

The objective for the present report, is to systematically summarize published results on effectiveness using nitrous oxide in a paediatric setting for small, but painful hospital procedures.

Health technology assessment

Published 14.08.2018

Autologous hematopoietic stem cell transplantation (AHSCT) for Diffuse Systemic Sclerosis. Health Technology Assessment

AHSCT is suggested for rapid and severe development of diffuse systemic sclerosis. We have summarized the effect and safety, conducted a cost analysis and discussed ethics related to the treatment.

Health technology assessment

Published 15.06.2018

The MicraTM Transcatheter Pacing System, a leadless pacemaker, in patients indicated for single-chamber ventricular pacemaker implantation: A single technology assessment

In this single technology assessment, we assessed a leadless pacemaker for patients indicated for single-chamber ventricular pacemaker implantation.

Health technology assessment

Published 09.04.2018

177Lutetium-based peptide receptor radionuclide therapy for treating neuroendocrine tumours: a health technology assessment

The Commission Forum representing the four National Regional Health Authorities (RHA) in Norway asked the Norwegian Institute of Public Health to conduct a full HTA of 177Lu-PRRT.

Health technology assessment

Published 23.03.2018

Diagnostic accuracy, clinical effectiveness and budget impact of screening BRCA1/2 mutation carriers by MRI. A health technology assessment

This is a HTA of the diagnostic accuracy, clinical effectiveness and budget impact of breast cancer screening using MRI in combination with mammography, for women with BRCA1/2 genetic mutations.

Projects

Health technology assessment of influenza vaccination of children (project description)
Disinvestment of medical technologies in Specialist Healthcare Services
Hyperbaric oxygen therapy for osteonecrosis - project plan
Health Technology Assessment of medicines used for multiple sclerosis
Prehospital CT in acute stroke or head injury

See all

Health Technology Assessments (HTA)

Reports

Patent foramen ovale closure, antiplatelet therapy or anticoagulation therapy alone for management of cryptogenic stroke

Hyperbaric oxygen therapy for osteonecrosis

Therapist-supported internet therapy for mental disorders

EXOGEN™ in the treatment of non-union fractures

Effectiveness and safety of nitrous oxide as sedation regimen in children – an HTA

Autologous hematopoietic stem cell transplantation (AHSCT) for Diffuse Systemic Sclerosis. Health Technology Assessment

The MicraTM Transcatheter Pacing System, a leadless pacemaker, in patients indicated for single-chamber ventricular pacemaker implantation: A single technology assessment

177Lutetium-based peptide receptor radionuclide therapy for treating neuroendocrine tumours: a health technology assessment

Diagnostic accuracy, clinical effectiveness and budget impact of screening BRCA1/2 mutation carriers by MRI. A health technology assessment

Projects

See also

Systematic reviews

Health service quality measurements

Health system analyses